Answers are grounded in this paper and cite their sources.
Altogether, our data suggest that components of the 19S proteasome could serve as prognostic biomarkers and novel therapeutic targets in AML and several other human malignancies.
No takes yet. Share an insight, caveat, or question.
Tychhon et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: